Arkolith/Insider Trading/AGLE/Form 4

Alspaugh Jonathan

Chief Financial OfficerAeglea BioTherapeutics, Inc. (AGLE) · full profile →Form 4 · filed Aug 18, 2021
Net Buying
Open-Market Buys
$263K
Open-Market Sells
$0
Net Open-Market Flow
$263K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 18, 2021Buy(P)7K$6.72$48K40K
Aug 17, 2021Buy(P)23K$6.50$152K33K
Aug 16, 2021Buy(P)10K$6.37$62K10K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-052272) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML